Spinal Cord Injury Pipeline Highlights Report 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Spinal Cord Injury Pipeline Highlights - 2017" drug pipelines to their offering.

Spinal Cord Injury Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Spinal Cord Injury market. It covers emerging therapies for Spinal Cord Injury in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Spinal Cord Injury pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Spinal Cord Injury pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Spinal Cord Injury pipeline products by the company.

Short-term Launch Highlights:

Find out which Spinal Cord Injury pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. Spinal Cord Injury Pipeline by Stages

2. Spinal Cord Injury Pipeline by Drug Class

3. Spinal Cord Injury Pipeline by Company

4. Spinal Cord Injury Phase 3 Clinical Trial Insights

5. Spinal Cord Injury Phase 2 Clinical Trial Insights

6. Spinal Cord Injury Phase 1 Clinical Trial Insights

7. Spinal Cord Injury Preclinical Research Insights

8. Spinal Cord Injury Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/sksm9c/spinal_cord

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs